Advanced search
Publication Cover
International Journal of Hyperthermia Volume 18, 2002 - Issue 3
Submit an article Journal homepage
199
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Intraoperative hyperthermia in conjunction with multi-schedule chemotherapy (pre-, intra- and post-operative), by-pass surgery, and post-operative radiotherapy for the management of unresectable pancreatic adenocarcinoma

V. E. Kouloulias Department of Radiotherapy, Medical School, University of Athens, Aretaieion Hospital, 76 Vas. Sophias Avenue, 11528 Athens, Greece
,
J. R. Kouvaris Department of Radiotherapy, Medical School, University of Athens, Aretaieion Hospital, 76 Vas. Sophias Avenue, 11528 Athens, Greece
,
K. S. Nikita Institute of Communication and Computer Systems Department of Electrical and Computer Engineering, National Technical University of Athens, 9 Iroon Polytechniou Street, Zografos 15773, Athens, Greece
,
B. C. Golematis 1st Department of Propaedeutic Surgery, Medical School, University of Athens, Hippocration Hospital, 114 Vas. Sophias Avenue, 11527 Athens, Greece
,
N. K. Uzunoglu Institute of Communication and Computer Systems Department of Electrical and Computer Engineering, National Technical University of Athens, 9 Iroon Polytechniou Street, Zografos 15773, Athens, Greece
,
K. Mystakidou Department of Radiotherapy, Medical School, University of Athens, Aretaieion Hospital, 76 Vas. Sophias Avenue, 11528 Athens, Greece
,
C. Papavasiliou Department of Radiotherapy, Medical School, University of Athens, Aretaieion Hospital, 76 Vas. Sophias Avenue, 11528 Athens, Greece
&
L. Vlahos Department of Radiotherapy, Medical School, University of Athens, Aretaieion Hospital, 76 Vas. Sophias Avenue, 11528 Athens, Greece
 show all
Pages 233-252 | Published online: 09 Jul 2009

  • Brennan MF, Moccia RD, Klimstra D. Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg 1996; 223: 506-11.
  • de Rooij PD, Rogatko A, Brennan MF. Evaluation of palliative surgical procedures in unresectable pancreatic cancer. Br J Surg 1991; 78: 1053-8.
  • Yeo CJ, Cameron JL. Improving results of pancreaticoduodenectomy for pancreatic cancer. World J Surg 1999; 23: 907-12.
  • Lillemoe KD, Cameron JL, Kaufman HS, Yeo CJ, Pitt HA, Sauter PK. Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg 1993; 217: 447-55.
  • Lillemoe KD, Cameron JL, Yeo CJ, Sohn TA, Nakeeb A, Sauter PK, Hruban RH, Abrams RA, Pzitt HA. Pancreaticoduodenectomy Does it have a role in the palliation of pancreatic cancer? Ann Surg 1996; 223: 718-25.
  • Livingston EH, Welton ML, Reber HA. Surgical treatment of pancreatic cancer. The United States experience. Int J Pancreatol 1991; 9: 153-7.
  • Gunderson L, Willett C. Pancreas and hepatobiliary tract In: Perez CA and Brady LW, eds. Principles and practice of radiation oncology, 3 edn. Philadelphia, USA: Lippincott-Raven publishers, 1997; 1467-74.
  • Kokubo M, Nishimura Y, Shibamoto Y, Sasai K, Kanamori S, Hosotani R, Imamura M, Hiraoka M. Analysis of the clinical benefit of intraoperative radiotherapy in patients undergoing macroscopically curative resection for pancreatic cancer. Int J Radiat Oncol Biolphys 2001;48: 1081-7.
  • Sindelar WF, Kinsella TJ. Studies of intraoperative radiotherapy in carcinoma of the pancreas. Ann Oncol 1999; 10 Suppl 4: 226-30.
  • Permert J, Hafstrom L, Nygren P, Glimelius B. A systematic overview of chemotherapy effects in pancreatic cancer. Acta Oncol 2001; 40: 361-70.
  • Cannobio L, Boccardo F, Cannata D, Gallotti P, Renzo E. Treatment of advanced pancreatic carcinoma with the somatostatin analogue BIM 23014. Cancer 1991; 69: 648-51.
  • Sulkowski U, Buchler M, PederzoH P, Arnold R, Dinse P, Kay A, Haus U, Beger HG. A phase II study of high-dose octreotide in patients with unresectable pancreatic carcinoma Eur J Cancer 1999; 35: 1805-8.
  • Rosenberg L. Pancreatic cancer: does octreotide offer any promise? Chemother 2001; 47 Suppl 2: 134-49.
  • Uonetto R, Pugliese P, Bruzzi P, Rosso R. No standard treatment is available for advanced pancreatic cancer. Eur J Cancer 1995; 31: 882-8.
  • Caporale A, Borrello A, Cosenza UM, Boccuzzi M, Izzo L, Costi U, et al. Surgery associated with intraoperative hyperthermia-chemotherapy in the treatment of malignant tumors of the digestive system with peritoneal carcinosis. G Chir 1999; 20: 241-5.
  • Colacchio TA, Coughlin C, Taylor J, Douple E, Ryan T, Crichlow RW. Intraoperative radiation therapy and hyperthermia. Morbidity and mortality from this combined treatment modality for unresectable intra-abdominal carcinomas. Arch Surg 1990; 125: 370-5.
  • Ryan TP, Colacchio TA, Douple EB, Strohbehn JW, Coughlin CT. Techniques for intraoperative hyperthermia with ultrasound the Dartmouth experience with 19 patients. Int J Hyperthermia 1992; 8: 407-21.
  • Ashayeri E, Bonney G, DeWitty RL, Goldson AL, Leffall LD, Thomas JN. Preliminary survivorship report on combined intraoperative radiation and hyperthermia treatments for unresectable pancreatic adenocarcinoma. J Natl Med Assoc 1993; 85: 36-40.
  • Yamada S, Takai Y, Nemoto K, Ogawa Y, Kakuto Y, Hoshi A, Sakamoto K, Kobari M, Matsuno M. Intraoperative radiation therapy combined with hyperthermia for pancreatic carcinoma. Int J Oncol 1992; 1: 795-8.
  • Herman TS, Teicher BA, Jochelson M, Svensson G, Coleman CN. Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies. Int J Hyperthermia 1988; 4: 143-58.
  • Matsuoka H, Sugimachi K, Abe R, Ueo H, AkiyosM T. Enchancement of cytoxitity by hyperthermia after a long-term culture with 5-fluoroucil in transformed cells. Anticancer Res 1992; 12: 1621-5.
  • Emi Y, Kohnoe S, Yoshida M, Takahashi I, Maehara Y, Sugimachi K. Hyperthermia enhances the inhibition of tumor growth by 1-(2-tetrahydrofuryl)-5-fuoroucil/uracil (1:4) in tumors in mice and humans. Cancer 1992; 70: 1177-82.
  • Uzunoglu NK, Angelikas EA, Cosmidis PA. A 432 MHz local hyperthermia system using indirectly cooled water loaded waveguide applicator. IEEE Trans Microwave Theory Tech 1987MTT-35: 106-11.
  • Kouloulias V, Uzunoglu NK, Nikita KS, Dardoufas C, Ko u vans J, Sandilos P, Amtypas C, Vlahos L. Two intracavitary hyperthermia applicators for oesophagus and rectal tumors. Temperature distributions in a phantom. Radiother Oncol 2000; 56: S218
  • Engin K. Biological rationale and clinical experience with hyperthermia Control Clin Trials 1996;17: 316-42.
  • Cox RS, Kapp DS. Correlation of thermal parameters with outcome in combined radiation therapy-hyperthermia trials. Int J Hyperthermia 1992; 8: 719-32.
  • Kapp DS, Cox RS. Thermal treatment parameters are most predictive of outcome in patients with single tumor nodules per treatment field in recurrent adenocarcinoma of the breast. Int J Radiat Oncol Biol Phys 1995; 33: 887-99.
  • Scott J, Huskisson EC. Accuracy of subjective measurements made with or without previous scores: an important source of error in serial measurement of subjective states. Ann Rheum Dis 1979; 38: 558-9.
  • Nunnaly, JC. Psychometric Theory, 2nd edn. New York: McGraw Hill, 1978.
  • Sidney Siegel N, Castellan J Jr, Nonparametric Statistics for the Behavioral Sciences, College Div, 2nd edn. New York, USA: McGraw Hill, 1988.
  • Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-70.
  • Cox DR. Regression models and life tables. J Royal Stat Soc 1972, 34; 187-220.
  • Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTQ. Int J Radiat Oncol Biol Phys 1995; 31: 1341-6.
  • Ghaneh P, Kawesha A, Howes N, Jones L, Neoptolemos JP. Adjuvant therapy for pancreatic cancer. World J Surg 1999; 23: 937-45.
  • Breslin TM, Hess KR, Harbison DB, Jean ME, Cleary KR, Dackiw AP, Wolff RA, Abbruzzese JL, Janjan NA, Crane CH, Vauthey JN, Lee JF, Pisters PW, Evans DB. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol 2001; 8: 123-32.
  • Bajetta E, Di Bartolomeo M, Stani SC, Artale S, Ricci SB, Bozzetti F, Mazzaferro V, Toffolatti L, Buzzoni R. Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility study. Int J Radiat Oncol Biol Phys 1999; 45: 285-9.
  • White R, Lee C, Anscher M, Gottfried M, Wolff R, Keogan M, Pappas T, Hurwitz H, Tyler D. Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas. Ann Surg Oncol 1999; 6: 4-7.
  • Lubbe AS, Herrmann R, Riess H, Huhn D. Microcirculatory effects of hyperthermia and 5-fluorouracil in the skin of nude mice Int J Microcirc Clin Exp 1993; 13: 205-17.
  • Shchepotin IB, Buras RR, Nauta RJ, Shabahang M, Soldatenkov VA, Evans SR. In vitro effect of 5-fluorouracil, verapamil and hyperthermia on the human pancreatic adenocarcinoma cell line ASPC-1. Chemother 1994; 40: 348-56.
  • Maeta M, Sawata T, Kaibara N. Effects of hyperthermia on the metabolism of 5-fluoroucil in vitro. Int J Hyperthermia 1993; 9: 105-13.
  • Poston GJ, Townsend CM Jr, Rajaraman S, Thompson JC, Singh P. Effect of somatostatin and tamoxifen on the growth of human pancreatic cancers in nude mice. Pancreas 1990; 5: 151-7.
  • Tang C, Biemond I, Verspaget HW, Offerhaus GJ, Lamers CB. Expression of somatostatin receptors in human pancreatic tumor. Pancreas 1998; 17: 80-4.
  • Burch PA, Block M, Schroeder G, Kugler JW, Sargent DJ, Braich TA, et al. Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer a North Central Cancer Treatment Group study. Clin Cancer Res 2000; 6: 3486-92.
  • Cullinan S, Moertel CG, Wieand HS, Schutt AJ, Krook JE, Foley JF, Norris BD, Kardinal CG, Tschetter LK, Barlow JF. A phase III trial on the therapy of advanced pancreatic carcinoma Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin. Cancer 1990; 65: 2207-12.
  • Glimelius B, Huffman K, Sjoden PO, Jacobsson G, Sellstrom H, Enander LK, Linne, T, Svensson C. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Am Oncol 1996; 7: 593-600.
  • Evans DB, Abbruzzese JL, Rich TA. Cancer of the pancreas. In: De Vita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles and practice of oncology, 5th edn, Philadelphia: Uppincot, 1997; 1054-77.
  • Kaiser MH, Ellenberg SS. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985; 120: 899-903.
  • Ghaneh P, Slavin J, Sutton R, Neoptolemos JP. Adjuvant therapy for pancreatic cancer. Swiss Surg 2000; 6: 289-95.
  • Neoptolemos JP, Dunn JA, Moffitt DD, Almond J, Beger H, Bassi C, Derrenis C, Fernandez-Cruz L, Lacaine F, Spooner D, Kerr DJ, Buchler M. ESPAC-1 interim results: a European, randomised study to assess the roles of adjuvant chemotherapy (5FU + Folinic acid) and adjuvant chemoradiation (40GY + 5FU) in resectable pancreatic cancer. Proc Am Soc Clin Oncol 2000; 19: 238 (abstr 923)
  • Perez CA, Kuske RR, Emami B, Fineberg B. Irradiation alone or combined with hyperthermia in the treatment of recurrent carcinoma of breast in the chest wall. A non-randomized comparison. Int J Hyperthermia 1986; 2: 179-87.
  • Overgaard J. The current and potential role of hyperthermia in radiotherapy. Int J Radiat Oncol Biol Phys 1989; 16: 535-49.
  • Merrick HW, Milligan AJ, Woldenberg LS, Ahuja RK, Dobelbower RR Jr. Intraoperative interstitial hyperthermia in conjunction with intraoperative radiation therapy in a radiation-resistant carcinoma of the abdomen: report on the feasibility of a new technique. J Surg Oncol 1987; 36: 48-51.
  • Shibamoto Y, Nishimura U, Abe M. Intraoperative radiotherapy and hyperthermia for unresectable pancreatic cancer. Hepatogastroenterol 1996; 43: 326-32.
  • Fisher BJ, Perera FE, Kocha W, Tomiak A, Taylor M, Vincent M, Bauman GS. Analysis of the clinical benefit of 5-fluorouracil and radiation treatment in locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 1999; 45: 291-5.
  • Andre T, Balosso J, Louvet C, Hannoun L, Houry S, Huguier M, Colonna M, Lotz JP, De Gramont A, Bellaiche A, Pare R, Touboul E, Izrael V. Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study. Int J Radiat Oncol Biol Phys 2000; 46: 903-11.
  • Luderhoff EC, Gonzalez Gonzalez D, Bakker P. Pilot study in locally advanced unresectable pancreas carcinoma using a combination of accelerated radiotherapy and continuous infusion of 5-fluorouracil. Radiother Oncol 1996; 40: 241-3.
  • Nishimura Y, Hosotani R, Shibamoto Y, Kokubo M, Kanamori S, Sasai K, Hiraoka H, Ohshio G, Imamura M, Takahashi M, Abe M. External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer analysis of survival rates and complications. Int J Radiat Oncol Biol Phys 1997; 39: 39-49.
  • Hermanek P. Tumors of the gastrointestinal tract and the pancreas: histopathology, staging and prognosis. Anticancer Res 1999; 19: 2393-6.
  • Cameron JL, Crist DW, Sitzmann JV, Hruban RH, Boitnott JK, Seidler AJ, et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991; 161: 120-4.
  • Abrams R, Grochow L, Chakravarthy A, Sohn T, Zahurak M, Haulk T, et al. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels Int J Radiat Oncol Biol Phys 1999; 44: 1039-46.
  • Cella D, Tulsky D. Measuring quality of life today: Methodological aspects. Oncol 1990; 4: 29-38.
  • Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997; 15:2403-13.
  • Oettle H, Arning M, Pelzer U, Arnold D, Stroszczynski C, Langrehr J, Reitzig P, Kindler M, Herrenberger J, Musch R, Korsten EW, Huhn D, Riess H. A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancer. Ann Oncol 2000; 11: 1267-72.
  • Wagener DJ, de Mulder PH, WiIs JA. Multimodality treatment of locally advanced pancreatic cancer. Ann Oncol 1994; 5 Suppl 3: 81-6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.